ALPS Advisors’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $461K | Buy |
6,283
+76
| +1% | +$5.58K | ﹤0.01% | 660 |
|
2025
Q1 | $709K | Sell |
6,207
-3,071
| -33% | -$351K | ﹤0.01% | 546 |
|
2024
Q4 | $468K | Sell |
9,278
-79,711
| -90% | -$4.02M | ﹤0.01% | 625 |
|
2024
Q3 | $4.12M | Sell |
88,989
-6,777
| -7% | -$314K | 0.03% | 253 |
|
2024
Q2 | $3.11M | Buy |
95,766
+8,122
| +9% | +$264K | 0.02% | 280 |
|
2024
Q1 | $2.21M | Buy |
87,644
+15,284
| +21% | +$385K | 0.02% | 333 |
|
2023
Q4 | $2.35M | Sell |
72,360
-3,345
| -4% | -$109K | 0.02% | 311 |
|
2023
Q3 | $2.06M | Buy |
75,705
+1,041
| +1% | +$28.4K | 0.02% | 318 |
|
2023
Q2 | $1.66M | Buy |
74,664
+3,576
| +5% | +$79.6K | 0.01% | 346 |
|
2023
Q1 | $1.54M | Sell |
71,088
-1,886
| -3% | -$40.9K | 0.01% | 356 |
|
2022
Q4 | $1.48M | Buy |
+72,974
| New | +$1.48M | 0.01% | 360 |
|
2022
Q3 | – | Sell |
-14,486
| Closed | -$344K | – | 1090 |
|
2022
Q2 | $344K | Sell |
14,486
-149
| -1% | -$3.54K | ﹤0.01% | 705 |
|
2022
Q1 | $330K | Buy |
+14,635
| New | +$330K | ﹤0.01% | 721 |
|
2021
Q1 | – | Sell |
-14,659
| Closed | -$383K | – | 886 |
|
2020
Q4 | $383K | Sell |
14,659
-299
| -2% | -$7.81K | ﹤0.01% | 559 |
|
2020
Q3 | $260K | Buy |
+14,958
| New | +$260K | ﹤0.01% | 709 |
|
2020
Q1 | – | Sell |
-25,433
| Closed | -$308K | – | 816 |
|
2019
Q4 | $308K | Sell |
25,433
-1,127
| -4% | -$13.6K | ﹤0.01% | 795 |
|
2019
Q3 | $375K | Sell |
26,560
-4,037
| -13% | -$57K | ﹤0.01% | 526 |
|
2019
Q2 | $341K | Sell |
30,597
-1,614
| -5% | -$18K | ﹤0.01% | 808 |
|
2019
Q1 | $378K | Sell |
32,211
-230
| -0.7% | -$2.7K | ﹤0.01% | 809 |
|
2018
Q4 | $433K | Sell |
32,441
-1,308
| -4% | -$17.5K | ﹤0.01% | 534 |
|
2018
Q3 | $473K | Buy |
33,749
+8,139
| +32% | +$114K | ﹤0.01% | 742 |
|
2018
Q2 | $403K | Sell |
25,610
-1,204
| -4% | -$18.9K | ﹤0.01% | 765 |
|
2018
Q1 | $441K | Buy |
26,814
+602
| +2% | +$9.9K | ﹤0.01% | 748 |
|
2017
Q4 | $473K | Hold |
26,212
| – | – | ﹤0.01% | 602 |
|
2017
Q3 | $506K | Buy |
+26,212
| New | +$506K | ﹤0.01% | 490 |
|